Your Search Results

AI for clinical and academic cardiology knowledge work: innovation or academic misconduct ? Literature search, data extraction and responsible use

19 May 2026 – From EuroPCR 2026

This session critically examines the role of artificial intelligence in clinical and academic cardiology, focusing on its application in literature search, evidence synthesis, and report structuring. It discusses responsible AI use, emphasizing the balance between assistance and academic integrity, and features a debate on authorship, transparency,...

Artificial intelligence and advanced imaging in coronary interventions

19 May 2026 – From EuroPCR 2026

This session explores the integration of artificial intelligence with advanced imaging modalities in coronary interventions. Topics include quantitative myocardial blood flow assessment via co-registered CCTA and angiography, AI-guided real-time procedural support, novel video frame interpolation techniques, high-risk plaque identification through AI-derived OCT stress mapping, and validation...

Atrioventricular valve interventions in unusual clinical scenarios

19 May 2026 – From EuroPCR 2026

This session presents a series of complex atrioventricular valve interventions performed in unusual clinical scenarios, illustrating innovative approaches such as transcatheter tricuspid valve-in-valve post-heart transplant, dual mitral and tricuspid clipping via single access, and TEER in congenital heart anomalies. It highlights procedural complexities and novel solutions...

When ECMO is used in complex pulmonary embolism

19 May 2026 – From EuroPCR 2026

Examine the critical role of extracorporeal membrane oxygenation (ECMO) in managing complex pulmonary embolism cases. This session covers ECMO-supported interventions for central pulmonary artery occlusions, combined treatments including thrombectomy, and unique cases such as right atrial thrombus complications and pioneering ECMO-supported thrombo-embolectomy procedures.

5-year outcomes after transcatheter or surgical aortic valve replacement in low-risk patients with aortic stenosis (Evolut Low Risk)

01 Apr 2025

Yohei Ohno provides his takeaways from the results of the Evolut Low Risk trial which was presented by Michael J. Reardon during the ACC.25 in Chicago.